glp 1 eye problems Ozempic Blindness: Should You Worry? GLP-1 Meds Reduce Risk of

Novo Nordisk and Eli Lilly continue to dominate., Although Pfizer discontinued its in-house oral GLP-1 candidate danuglipron in April 2025 following a liver-injury signal, it has doubled back into obesity and GLP-1 with its multi-billion-dollar acquisition of Metsera

Stilgenbauer S, Goodacre A, Grace C, Andreeff M

Bain J, Plater L, Elliott M, Natalia Shpiro C, Hastie J, Mclauchlan H, Iva Klevernic J, Arthur SC, Alessi DR, Cohen P (2007) The selectivity of protein kinase inhibitors: a further update

Dialectical Behavioral Therapy (DBT) DBT is another effective BED treatment, originally developed to address borderline personality disorder